Iscan, M. Et Al. 2017. CYP1B1*2 and CYP1B1*3 polymorphisms and clinical outcome in non-small cell lung cancer patients. 53rd Congress of the European-Societies-of-Toxicology (EUROTOX) , (Bratislava, Slovakia).

Iscan, M., ADA, A. O., Guler, A., Kunak, C. S., & Gulhan, M., (2017). CYP1B1*2 and CYP1B1*3 polymorphisms and clinical outcome in non-small cell lung cancer patients . 53rd Congress of the European-Societies-of-Toxicology (EUROTOX), Bratislava, Slovakia

Iscan, Mumtaz Et Al. "CYP1B1*2 and CYP1B1*3 polymorphisms and clinical outcome in non-small cell lung cancer patients," 53rd Congress of the European-Societies-of-Toxicology (EUROTOX), Bratislava, Slovakia, 2017

Iscan, Mumtaz Et Al. "CYP1B1*2 and CYP1B1*3 polymorphisms and clinical outcome in non-small cell lung cancer patients." 53rd Congress of the European-Societies-of-Toxicology (EUROTOX) , Bratislava, Slovakia, 2017

Iscan, M. Et Al. (2017) . "CYP1B1*2 and CYP1B1*3 polymorphisms and clinical outcome in non-small cell lung cancer patients." 53rd Congress of the European-Societies-of-Toxicology (EUROTOX) , Bratislava, Slovakia.

@conferencepaper{conferencepaper, author={Mumtaz Iscan Et Al. }, title={CYP1B1*2 and CYP1B1*3 polymorphisms and clinical outcome in non-small cell lung cancer patients}, congress name={53rd Congress of the European-Societies-of-Toxicology (EUROTOX)}, city={Bratislava}, country={Slovakia}, year={2017}}